Company family · public contract awards

Themis Beteiligungs public contracts.

Themis Beteiligungs is a family of 3 companies that won 656 public contracts in 2 countries, headed by Themis Beteiligungs-Aktiengesellschaft (Germany). Its companies' largest customer is Techniker Krankenkasse (80 contracts). Latest award: Mar 2026.

656Contracts won
3Companies
2Countries
Mar 2026Latest award

Latest contracts won

Arzneimittelvergaben zum 01.01.2026 und 01.07.2026
Won by mibe GmbH Arzneimittel · awarded by Pbmg Eg · Germany
3 Mar 2026Awarded
Generika-Ersatzkassen 20
Won by mibe GmbH Arzneimittel · awarded by DAK-Gesundheit · Germany
30 Aug 2024Awarded
Generika-Ersatzkassen 20
Won by Dermapharm AG · awarded by DAK-Gesundheit · Germany
30 Aug 2024Awarded
Ersatzkassen-Generika Nr. 22
Won by mibe GmbH Arzneimittel · awarded by Techniker Krankenkasse · Germany
13 Aug 2024Awarded
Arzneimittelvergaben zum 1.Juli 2024
Won by mibe GmbH Arzneimittel · awarded by Pbmg Eg · Germany
9 Jul 2024Awarded
Ersatzkassen-Generika Nr. 21
Won by Dermapharm AG · awarded by Techniker Krankenkasse · Germany
20 Jun 2024Awarded
31. Generikaausschreibung (1a)
Won by Dermapharm AG · awarded by GWQ ServicePlus AG · Germany
22 Apr 2024Awarded
Arzneimittelausschreibung
Won by mibe GmbH Arzneimittel · awarded by IKK classic · Germany
10 Apr 2024Awarded
Arzneimittelausschreibung
Won by Dermapharm AG · awarded by IKK classic · Germany
10 Apr 2024Awarded
31. Generikaausschreibung (2;3er)
Won by mibe GmbH Arzneimittel · awarded by GWQ ServicePlus AG · Germany
3 Apr 2024Awarded
31. Generikaausschreibung (Sustainability) - Auftragsvergabe
Won by Dermapharm AG · awarded by GWQ ServicePlus AG · Germany
3 Apr 2024Awarded
24 (2;3)
Won by mibe GmbH Arzneimittel · awarded by Gemeente Rotterdam · Germany
9 Feb 2024Awarded
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Fusidinsäure (D06AX01) im Rahmen e
Won by Dermapharm AG · awarded by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany
12 Jan 2024Awarded
30. Generikaausschreibung (1)
Won by Dermapharm AG · awarded by GWQ ServicePlus AG · Germany
13 Nov 2023Awarded
48. Generika-Ausschreibung_FL
Won by mibe GmbH Arzneimittel · awarded by spectrumK GmbH · Germany
18 Oct 2023Awarded
48. Generika-Ausschreibung_FL
Won by Dermapharm AG · awarded by spectrumK GmbH · Germany
18 Oct 2023Awarded
29. Generikaausschreibung (1)
Won by mibe GmbH Arzneimittel · awarded by GWQ ServicePlus AG · Germany
27 Sep 2023Awarded
29. Generikaausschreibung (2;3)
Won by Dermapharm AG · awarded by GWQ ServicePlus AG · Germany
27 Sep 2023Awarded
29. Generikaausschreibung (1)
Won by Dermapharm AG · awarded by GWQ ServicePlus AG · Germany
27 Sep 2023Awarded
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2023-07
Won by mibe GmbH Arzneimittel · awarded by Deutsche Rentenversicherung Knappschaft-Bahn-See · Germany
11 Sep 2023Awarded

Contracts won by year

Contracts won by year

from the published records
201430
201519
201625
201724
201834
201945
202042
202132
202235
202325
202432
20262

Published value, by currency

EUR · 38 valued
€64.03 million

The family adds up the public contract awards of every company below. Who belongs to the family comes from GLEIF, the global register of legal entities (Legal Entity Identifier 529900EU5UITF6SZS722, accounting consolidation); 0 companies were matched by registry number and the rest by exact legal name in their country. Each currency is shown on its own and never converted.

Bid with askTender

Bidding against Themis Beteiligungs?

askTender reads any open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

askTender See open tenders